UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:April 07,
Orgenesis (NASDAQ:ORGS)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Orgenesis Charts.
Orgenesis (NASDAQ:ORGS)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Orgenesis Charts.

Orgenesis Inc. News

Form ARS - Annual Report to Security Holders
Monday 6 May 2024 (1 day ago) • Edgar (US Regulatory)
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Monday 6 May 2024 (1 day ago) • Edgar (US Regulatory)
Form DEF 14A - Other definitive proxy statements
Monday 6 May 2024 (1 day ago) • Edgar (US Regulatory)
Orgenesis Provides Year End Business Update
Monday 15 April 2024 (3 weeks ago) • GlobeNewswire Inc.
Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility
Wednesday 10 April 2024 (4 weeks ago) • GlobeNewswire Inc.
Vered Caplan, CEO of Orgenesis, to Present at the Bioprocessing Summit Europe Conference
Monday 18 March 2024 (2 months ago) • GlobeNewswire Inc.
Orgenesis Consortium Awarded €1.5M EUR Grant from the Walloon Government in Belgium for EXOFASTTRACK Project Dedicated to Accelerated Development of Multiple Therapeutic Exosomes
Wednesday 13 March 2024 (2 months ago) • GlobeNewswire Inc.
Orgenesis Inc. Announces $2.3 Million Private Placement
Monday 4 March 2024 (2 months ago) • GlobeNewswire Inc.
Orgenesis Consortium Awarded €2.0M EUR Grant from Walloon Government in Belgium for MAIDAM AI Project for Monitoring Decentralized ATMP Manufacturing
Thursday 29 February 2024 (2 months ago) • GlobeNewswire Inc.
Form 8-K - Current report
Wednesday 31 January 2024 (3 months ago) • Edgar (US Regulatory)
Orgenesis Acquires Control of Octomera with the Goal of Progressing its Decentralized Immuno-Oncology Portfolio to Clinic
Wednesday 31 January 2024 (3 months ago) • GlobeNewswire Inc.
Form 8-K - Current report
Wednesday 24 January 2024 (3 months ago) • Edgar (US Regulatory)

More Orgenesis Inc. News Articles